May 5, 2026 04:34PM
May 5, 2026 04:01PM
Apr 29, 2026 08:00AM
Feb 12, 2026 04:30PM
Feb 12, 2026 04:01PM
Feb 5, 2026 04:05PM
Jan 12, 2026 07:31AM Ultragenyx reports preliminary 2025 revenue of $672-674 million
Jan 12, 2026 07:30AM
Dec 29, 2025 12:04PM
Nov 4, 2025 04:19PM
Nov 4, 2025 04:05PM
Oct 28, 2025 04:30PM
Aug 5, 2025 04:01PM
Jul 30, 2025 08:30AM Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update
Jul 9, 2025 04:05PM
Jul 9, 2025 04:05PM
May 6, 2025 04:48PM
May 6, 2025 04:01PM
Apr 30, 2025 05:00PM
Apr 2, 2025 07:04AM
Feb 14, 2025 06:57AM Goldman Sachs Reiterates Buy Rating on Ultragenyx Pharma (RARE)
Feb 13, 2025 04:50PM
Feb 13, 2025 04:01PM
Feb 6, 2025 04:30PM
Jan 12, 2025 11:00AM
Dec 11, 2024 08:30AM
Nov 5, 2024 04:14PM
Nov 5, 2024 04:01PM Ultragenyx Reports Third Quarter 2024 Financial Results and Corporate Update
Oct 29, 2024 04:05PM
Aug 1, 2024 05:34PM
Aug 1, 2024 04:05PM
Jul 25, 2024 04:05PM
Jul 9, 2024 07:00PM
Jun 12, 2024 08:12AM
Jun 11, 2024 05:47PM Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Os
May 2, 2024 04:14PM
May 2, 2024 04:00PM
Apr 25, 2024 04:30PM
Apr 25, 2024 04:30PM
Apr 24, 2024 09:42AM
Feb 15, 2024 04:05PM
Feb 15, 2024 04:01PM Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Feb 8, 2024 04:00PM
Jan 8, 2024 07:00AM
Jan 8, 2024 05:20AM
Jan 7, 2024 11:00AM
Nov 2, 2023 05:03PM
Nov 2, 2023 04:05PM
Oct 26, 2023 04:05PM Ultragenyx to Host Conference Call for Third Quarter 2023 Financial Results and Corporate Update
Oct 23, 2023 04:02PM

1,199,636 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All